Grand River Aseptic Manufacturing (GRAM), has appointed industry veteran David Powell to its executive team as vice president of business development.

“I am honored to join the GRAM family. The quality focus, impressive facility expansion, and company culture stand out. It’s a privilege to be part of this team,” said David. “I look forward to educating the biopharmaceutical industry on the quality processes, capabilities, and customer service found at GRAM.”

Prior to joining the company, David held leadership roles at Abbott, Hospira, and most recently, Pfizer. As Pfizer’s senior director, Development Services and Commercial Accounts, he headed the global Development Services and Commercial Accounts organizations of the CentreOne contract development and manufacturing business, including accountability for customer management. David has led personnel in Europe, India, Japan and Australia.  

“I am thrilled to welcome Dave to our team as GRAM is ready to embark upon a significant expansion.  Dave has a strong passion for pharmaceutical manufacturing with a focus on quality.  His organization leadership and commercial-scale project expertise are invaluable as we continue to grow,” said Tom Ross, president and chief executive officer. “I look forward to working with Dave and seeing all he will accomplish in leading our business development efforts. GRAM’s continued focus on exceptional quality, superior customer service and excellent technical competency will enable Dave to build upon our amazing growth.”

Expected to open in 2020, GRAM’s 60,000 sq.-ft. Butterworth facility will provide additional manufacturing capacity and high quality solutions for customers with biologic and small molecule projects. The new facility will be GRAM’s fifth location in Grand Rapids.